CMS: Prescription drug costs are growing problem

Cara Livernois | April 28, 2016 | Health Exec | Economics

Drug prices rose 12 percent in 2015 and national spending on cancer and hepatitis drugs and other special medicines has doubled in the past five years.

"If we don't address this problem in the next four or five years, and prescription drug costs grow as they've been growing, this will be one of the top three issues for my successor, if not the No. 1 issue," said Andy Slavitt, administrator for Centers for Medicare & Medicaid Services.

Around the web

Cardiovascular Business

Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.

AI in Healthcare

A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

CMS: Prescription drug costs are growing problem

Related Content

Around the web